Can blood tests reveal how liver and bile duct cancers respond to treatment?

NCT ID NCT06877637

Recruiting now Knowledge-focused Sponsor: Region Skane Source: ClinicalTrials.gov ↗

First seen Aug 03, 2026 · Last updated Aug 04, 2026 · Updated 1 time

Summary

This study follows 150 adults with liver or bile duct cancer who are receiving standard treatments like surgery, ablation, or chemotherapy. Researchers will collect repeated blood samples before, during, and after treatment to analyze tumor DNA, immune cells, and proteins. The goal is to understand how individual and tumor-related factors influence treatment response and overall survival.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could help doctors predict how well liver and bile duct cancers respond to treatment, potentially leading to more personalized therapy plans.
What could go wrong: This is an observational study, so it won't test a new treatment. It may not lead to immediate changes in care, and results depend on the diversity of participants and tumor types.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHOLANGIOCARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

bile duct neoplasm cholangiocarcinoma combined hepatocellular carcinoma and cholangiocarcinoma distal biliary tract carcinoma gallbladder carcinoma hepatocellular carcinoma intrahepatic cholangiocarcinoma perihilar intrahepatic cholangiocarcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHOLANGIOCARCINOMA HEPATOCELLULAR CARCINOMA (HCC)

Contacts and locations

Locations

Onkologimottagning Central Hospital in Kristianstad
RECRUITING

Kristianstad, 29185, Sweden
VE Onkologi Skåne University Hospital
RECRUITING

Lund, 22185, Sweden
VO kirurgi och gastroenterologi Skåne University Hospital
RECRUITING

Lund, 22185, Sweden

More trials for these conditions

Other studies related to the condition(s) this trial covers.